Results of dexamethasone intravitreal implant (Ozurdex) in diabetic macular edema patients: Early versus late switch.

Jorge Ruiz-MedranoRamón Rodríguez-LeorElena AlmazánFrancisco LugoEsther Casado-LopezLuis AriasJose Maria Ruiz-Moreno

Published in: European journal of ophthalmology (2020)

In eyes with insufficient response to antivascular endothelial growth factor inhibitors, switching to dexamethasone at the time to 3-monthly antivascular endothelial growth factor inhibitors injections provided better functional outcomes than those that received >3 antivascular endothelial growth factor inhibitors injections.

Keyphrases

growth factor
endothelial cells
end stage renal disease
ejection fraction
low dose
high dose
chronic kidney disease
prognostic factors
ultrasound guided
peritoneal dialysis
platelet rich plasma
optical coherence tomography
diabetic retinopathy
patient reported outcomes
patient reported